Intelligent, Adaptive, and Personalized Drug Delivery System

A next-generation drug delivery system that integrates real-time vital sign monitoring, artificial intelligence-driven dosing algorithms, and wearable injector devices for personalized and adaptive fluid delivery.

The original patent's drive assembly and spacer for drug delivery systems have limitations in terms of user experience, safety, and efficacy. The new inventive concept addresses these limitations by incorporating advanced sensing, AI-driven decision-making, and modular design to provide a more efficient, personalized, and safe drug delivery experience.

The new inventive concept comprises a wearable injector device with an integrated sensor for real-time monitoring of the patient's vital signs, a self-adjusting needle depth control mechanism, and a personalized dosing algorithm for customized fluid delivery. The system also includes a modular, interchangeable container assembly with a self-contained power source, a wireless communication module for remote software updates, and a dynamic needle actuator that adapts to varying skin types and injection depths. The artificial intelligence module analyzes the patient's medical history and automatically adjusts the injection parameters, transmitting the injection data to a remote monitoring platform for real-time tracking and analysis.

The new inventive concept's integration of AI-driven dosing algorithms, real-time vital sign monitoring, and modular design represents a significant departure from the original patent's mechanical drive assembly and spacer. The use of artificial intelligence to optimize fluid delivery parameters and the incorporation of wearable injector devices with advanced sensing capabilities are novel and non-obvious features that provide a substantial improvement over existing drug delivery systems.

Alternative embodiments of the inventive concept could include the use of different sensing modalities, such as electroencephalography (EEG) or electromyography (EMG), to monitor the patient's physiological responses. The system could also be adapted for use in different therapeutic areas, such as diabetes management or pain relief. Additionally, the artificial intelligence module could be trained using different machine learning algorithms or data sources to optimize fluid delivery parameters.

The new inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of diabetes management, pain relief, and immunotherapy. The system's ability to provide personalized and adaptive fluid delivery could improve patient outcomes, reduce healthcare costs, and enhance the user experience. The market for wearable injector devices and AI-driven drug delivery systems is expected to grow significantly in the coming years, driven by increasing demand for personalized medicine and digital health solutions.